Selected article for: "cytotoxic concentration and half maximal inhibitory concentration"

Author: jose-carlos Valle-Casuso; Delphine Gaudaire; Lydie Martin-Faivre; anthony madeline; Patrick Dallemagne; Stephane Pronost; Helene Munier-Lehmann; Stephan Zientara; Pierre-Olivier Vidalain; Aymeric Hans
Title: Replication of Equine arteritis virus is efficiently suppressed by purine and pyrimidine biosynthesis inhibitors
  • Document date: 2020_4_10
  • ID: my4n0vye_9
    Snippet: The half maximal toxic concentration (TC 50 ), which is the concentration that kills 50% of the cells in 154 culture, was estimated to be >100 µg/ml for ribavirin. Then, we tested the effect of ribavirin in our in 155 vitro EAV infection model at the non-cytotoxic concentration range of 0.5 to 20 µg/ml. As shown in 156 Figure 3A , ATP quantification in infected culture wells at 48 h showed that only 35% of cells were alive 157 in the absence of.....
    Document: The half maximal toxic concentration (TC 50 ), which is the concentration that kills 50% of the cells in 154 culture, was estimated to be >100 µg/ml for ribavirin. Then, we tested the effect of ribavirin in our in 155 vitro EAV infection model at the non-cytotoxic concentration range of 0.5 to 20 µg/ml. As shown in 156 Figure 3A , ATP quantification in infected culture wells at 48 h showed that only 35% of cells were alive 157 in the absence of ribavirin as opposed to 67% in presence of the drug at 0.5 µg/ml. The viability of 158 infected cells was above 80% when treated with ribavirin at 2, 5 or 10 µg/ml ( Figure 3A ). These results 159 were used to calculate the half maximal inhibitory concentration (IC 50 ) of ribavirin that was estimated 160 to 0.90 µg/ml, i.e. 3.7 µM. This demonstrates that ribavirin is able to protect ED cells against EAV-161 associated cytopathic effects. 162

    Search related documents:
    Co phrase search for related documents
    • µg ml and cytopathic effect: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19
    • µg ml and EAV infection: 1, 2
    • µg ml and ED cell: 1
    • µg ml and half maximal inhibitory concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • µg ml and infected cell: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • µg ml and inhibitory concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • µg ml and ribavirin effect: 1, 2, 3
    • µg ml and ribavirin treat: 1
    • associated cytopathic effect and cytopathic effect: 1, 2, 3
    • ATP quantification and EAV infection: 1
    • ATP quantification and EAV infection model: 1
    • ATP quantification and ED cell: 1
    • ATP quantification and infected cell: 1
    • concentration range and cytopathic effect: 1, 2
    • concentration range and half maximal inhibitory concentration: 1
    • concentration range and inhibitory concentration: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • concentration range and ribavirin effect: 1, 2
    • cytopathic effect and infected cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cytopathic effect and ribavirin effect: 1